» Articles » PMID: 31609932

Vasoactive Intestinal Peptide-Secreting Tumors: A Review

Overview
Journal Pancreas
Specialty Gastroenterology
Date 2019 Oct 15
PMID 31609932
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Vasoactive intestinal peptide-secreting tumors (VIPomas) are a group of rare neuroendocrine tumors, which cause a typical syndrome of watery diarrhea. Most of these tumors are found in the pancreas and are usually detected at a later stage. Although curative resection is not possible in most of these tumors, both symptom and tumor control can be achieved by a multidimensional approach, to enable a long survival of most patients. There are no clear-cut guidelines for the management of VIPomas because of the rarity of this neoplasm and lack of prospective data. In this review, we discuss the available evidence on the clinical features and management of these rare tumors.

Citing Articles

Interference With VIP to Distinguish Between Real and False VIPoma: National Study From the French Endocrine Tumors Group.

Chevalier B, Bonnet D, Lepage C, Perrier M, Borson-Chazot F, Abeillon J J Endocr Soc. 2024; 8(7):bvae102.

PMID: 38854908 PMC: 11156571. DOI: 10.1210/jendso/bvae102.


Chronic Diarrhea Caused by Vasoactive Intestinal Peptide-Secreting Tumor.

Belei O, Basaca D, Heredea E, Iacob E, Olariu L, Folescu R Life (Basel). 2023; 13(10).

PMID: 37895355 PMC: 10608053. DOI: 10.3390/life13101974.


A Comprehensive Review on Neuroendocrine Neoplasms: Presentation, Pathophysiology and Management.

Sultana Q, Kar J, Verma A, Sanghvi S, Kaka N, Patel N J Clin Med. 2023; 12(15).

PMID: 37568540 PMC: 10420169. DOI: 10.3390/jcm12155138.


Pressure-Dependent Elevation of Vasoactive Intestinal Peptide Level in Chicken Choroid.

Privalov E, Zenkel M, Schloetzer-Schrehardt U, Kuerten S, Bergua A, Hohberger B Biology (Basel). 2023; 12(4).

PMID: 37106696 PMC: 10136289. DOI: 10.3390/biology12040495.


Management of Functional Pancreatic Neuroendocrine Neoplasms.

Magi L, Marasco M, Rinzivillo M, Faggiano A, Panzuto F Curr Treat Options Oncol. 2023; 24(7):725-741.

PMID: 37103745 PMC: 10272249. DOI: 10.1007/s11864-023-01085-0.